In today’s complex oncology landscape, administering chemotherapy or specialty medications isn’t just about clinical care — it’s also about compliance, financial planning, and operational discipline. Oncologists face a daily challenge: Should the clinic supply the drug through the buy-and-bill model, or should it be filled via a pharmacy?

While reimbursement rules and payer preferences matter, many practices overlook a critical factor — their internal readiness to manage these drugs correctly.

Let’s explore why operational readiness is the foundation for making smart decisions in oncology drug delivery.

Trained Infusion Staff: The First Line of Defense

In-house drug administration demands more than just physical space. Your infusion staff must be highly trained to handle complex chemotherapy regimens, biologics, and hazardous drugs. Proper technique, USP <800> compliance, safety protocols, and monitoring for infusion reactions all come into play.

Without well-trained staff, the risk of errors — both clinical and legal — increases exponentially. For clinics considering buy-and-bill, this is non-negotiable.

The Role of an Expert Biller

Even the best clinical decision can result in revenue loss if your billing team isn’t skilled in oncology-specific coding and reimbursement. Billing infused or injected drugs requires knowledge of:

1. HCPCS Level II drug codes (J-codes)
2. NDC-to-HCPCS crosswalks
3. Dosage-based billing
4. Modifiers for wastage
5. Administration codes

On top of that, billers must understand payer-specific nuances and documentation needs to avoid denials and delays. In short, your revenue depends on your biller’s expertise.

Choosing the Right EMR for Oncology

Not every EMR is designed to handle the complexities of oncology drug management. A good EMR should:

1. Track inventory of in-house drugs
2. Integrate with billing systems for correct coding
3. Support prior authorization workflows
4. Document drug units and wastage accurately
5. Interface with payer eligibility and benefits systems

Without a robust EMR, your practice may struggle to stay compliant — or even profitable — especially when managing high-cost infusions in the buy-and-bill model.

Eligibility and Benefit Verification: Don’t Skip This Step

Before a single vial is ordered or administered, eligibility and benefit verification must be performed. This step confirms:

1. Whether the drug is covered under the patient’s medical or pharmacy benefit
2. Whether prior authorization is needed
3. Patient co-pay responsibilities
4. Any step therapy or quantity limits

Failing to verify this information can lead to unreimbursed claims, billing delays, or angry patients stuck with unexpected costs. This isn’t just a billing issue — it’s a patient care issue.

Summary

For oncologists, the decision between buy-and-bill and pharmacy-supplied drugs is no longer just about payer policy. It’s about how ready your clinic is to manage the clinical, financial, and administrative load that comes with each model. Trained staff, skilled billers, integrated EMRs, and timely benefit checks are the foundation of effective oncology drug delivery.

Want to evaluate if your practice is ready? Talk to our experts at Confair Technologies and ensure your operational setup is optimized for today’s oncology challenges.